EARNEST Partners’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-58
| Closed | -$937 | – | 829 |
|
|
2023
Q3 | $937 | Hold |
58
| – | – | ﹤0.01% | 1075 |
|
|
2023
Q2 | $2.41K | Hold |
58
| – | – | ﹤0.01% | 969 |
|
|
2023
Q1 | $3.49K | Hold |
58
| – | – | ﹤0.01% | 875 |
|
|
2022
Q4 | $4.25K | Hold |
58
| – | – | ﹤0.01% | 831 |
|
|
2022
Q3 | $4K | Hold |
58
| – | – | ﹤0.01% | 842 |
|
|
2022
Q2 | $4K | Hold |
58
| – | – | ﹤0.01% | 865 |
|
|
2022
Q1 | $5K | Hold |
58
| – | – | ﹤0.01% | 850 |
|
|
2021
Q4 | $4K | Hold |
58
| – | – | ﹤0.01% | 918 |
|
|
2021
Q3 | $7K | Hold |
58
| – | – | ﹤0.01% | 758 |
|
|
2021
Q2 | $13K | Hold |
58
| – | – | ﹤0.01% | 589 |
|
|
2021
Q1 | $8K | Hold |
58
| – | – | ﹤0.01% | 707 |
|
|
2020
Q4 | $10K | Hold |
58
| – | – | ﹤0.01% | 622 |
|
|
2020
Q3 | $6K | Buy |
+58
| New | +$6K | ﹤0.01% | 712 |
|